tiprankstipranks

Michael Halstead Insider Profile

4 Followers
Michael Halstead, President at Intra-Cellular Therapies, holds 0.00 shares in Intra-Cellular Therapies (Ticker: ITCI), holds 15.36K shares in Warner Chilcott (Ticker: WCRX).
tipranks
Michael Halstead

Michael Halstead
Intra-Cellular Therapies (ITCI)
President

Ranked #24,316 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+87.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Michael Halstead does not currently own shares as a corporate insider.
A breakdown of Michael Halstead's holdings

Insider Roles

Intra-Cellular Therapies
(ITCI)
President
Roles that Michael Halstead holds in companies

Most Profitable Insider Trade

Stock:
Intra-Cellular Therapies
(ITCI)
Rating:Informative Buy
Date:Nov 06, 2014 - Nov 06, 2015
Return:+229.90%
The most profitable trade made by Michael Halstead

Michael Halstead's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Intra-Cellular Therapies
Nov 14, 2024
President
Uninformative Buy
1.24M
$0.00
WCRX
Warner Chilcott
Jun 02, 2011
Uninformative Buy
List of latest transactions for each holding click on a transaction to see Michael Halstead's performance on stock

Michael Halstead insider profile FAQ

What is the percentage of profitable transactions made by Michael Halstead?
The percentage of profitable transactions made by Michael Halstead is 50%.
    What is the average return per transaction made by Michael Halstead?
    The average return per transaction made by Michael Halstead is 87.40%.
      What stocks does Michael Halstead hold?
      Michael Halstead holds: ITCI, WCRX stocks.
        What was Michael Halstead’s latest transaction?
        Michael Halstead latest transaction was an Uninformative Buy of $1.24M.
          What was Michael Halstead's most profitable transaction?
          Michael Halstead’s most profitable transaction was an Informative Buy of ITCI stock on November 6, 2014. The return on the trade was 229.90%.
            What is Michael Halstead's role in Intra-Cellular Therapies?
            Michael Halstead's role in Intra-Cellular Therapies is President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.